St. Louis — AUGUST 9, 2016 – Lumeris, a pioneer in population health management solutions headquartered in St. Louis, is pleased to announce Dr. Lance W. Coleman will serve as medical director. Dr. Coleman will be responsible for providing payers and providers with the necessary tools to deliver high-quality, cost-effective healthcare. With nearly 20 years (…)
Austin — AUGUST 4, 2016 – Lumeris, a long-term operating partner for healthcare organizations that are committed to the transition from volume- to value-based care, announced today that Ray Wolf has joined its Austin team as senior vice president of architecture and innovation. In his role, Wolf will develop new enterprise products to enhance Lumeris’ (…)
ST. LOUIS — AUGUST 2, 2016 – Lumeris, a pioneer in population health management solutions headquartered in St. Louis, is pleased to announce the appointment of Joseph Gifford, MD, as senior vice president of Provider Markets. Dr. Gifford, a healthcare industry veteran with proven experience at high-growth healthcare organizations, will play a key role in (…)
Today, Lumeris, a pioneer in population health management solutions headquartered in St. Louis, announced that Art Glasgow joined the company as president and chief operating officer (COO). In this position, Glasgow will play a key role in setting Lumeris’ strategy for continued growth as the company accelerates innovation and blazes a trail for the healthcare industry’s (…)
Mike Long, CEO of Lumeris, Accepts Award in New Category at HIMSS 2016 Award Ceremony
KLAS recently released a report naming Lumeris the top-rated value-based care managed services provider in the area of client-reported impact on the Triple Aim. In this blog post, Peter Kinhan discuss the five reasons operating partners are critical for the transformation to value-based care.
News Release: KLAS Report Names Lumeris A Top-Performing Solution For Value-Based Care Managed Services
Lumeris has been named the top-rated value-based care managed services providers in the area of client-reported impact on the Triple Aim by KLAS Research.